Form 4 Filing for Aquestive Therapeutics, Inc.

Daniel Barber, President and CEO of Aquestive Therapeutics, Inc., reported a sale of 25,000 shares of common stock on September 15, 2026. The transactions occurred at prices ranging from $4.78 to $4.90 per share, with a weighted average price of $4.8195 per share. Following these transactions, Barber owns 652,317 shares. The reporting person has committed to providing further details on the sale prices upon request. This filing is significant due to the direct involvement of a high-ranking executive in a stock sale.